Physician profile
Jonathan S Nelson
NPI 1285991851
$6,437.88
in general payments reported to CMS, 2019-2025
39 companies · $1,494 in 2025
The $1,494 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $113 · 2021: $239 · 2022: $607 · 2023: $463 · 2024: $3,296 · 2025: $1,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,216 · Travel and Lodging: $1,774 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,216.46 |
| Travel and Lodging | $1,774.00 |
| Education | $263.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,143.28 | 2023-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $729.58 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $617.29 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $261.98 | 2019-2025 | Lithovue, Moses 550 Dfl, Rezum Generator |
| Medtronic, INC. | $238.54 | 2022-2024 | Interstim |
| Sumitomo Pharma America, INC. | $237.31 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $226.74 | 2024-2025 | Aquabeam System |
| Pfizer INC. | $211.40 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $197.67 | 2024-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $188.26 | 2022-2025 | |
| Urogen Pharma, INC. | $118.45 | 2023-2025 | Jelmyto |
| Olympus America INC. | $117.06 | 2024-2025 | Itind System, Soltive |
| Verity Pharmaceuticals INC. | $113.86 | 2023-2025 | Trelstar, Tlando |
| Tolmar Pharmaceuticals, INC. | $92.94 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $81.62 | 2021-2025 | Keytruda, Keytruda Qlex |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $81.50 | 2019-2023 | Da Vinci Surgical System |
| Antares Pharma, INC. | $76.00 | 2025 | Xyosted |
| Immunitybio, INC. | $75.71 | 2025 | |
| Abbvie INC. | $68.20 | 2022-2024 | |
| Valencia Technologies Corporation | $54.11 | 2025 | Ecoin Device Kit |
| Ferring Pharmaceuticals INC. | $47.04 | 2024 | Adstiladrin |
| Civco Medical Instruments | $42.20 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $41.54 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Dornier Medtech America, INC | $39.98 | 2020 | |
| Tolmar, INC. | $38.10 | 2023 | |
| Novartis Pharmaceuticals Corporation | $31.40 | 2023 | |
| Coloplast Corp | $29.88 | 2024 | |
| Tempus Ai, INC | $29.53 | 2024 | |
| Urovant Sciences INC | $26.70 | 2021-2022 | |
| Innovation Technologies INC | $24.02 | 2024 | Irrisept |
| Telix Pharmaceuticals | $22.61 | 2024 | Illuccix |
| Endo USA, INC. | $19.42 | 2024 | Xiaflex |
| Allergan, INC. | $18.61 | 2022 | |
| Progenics Pharmaceuticals, INC. | $18.15 | 2023 | Pylarify |
| Cook Medical LLC | $16.95 | 2024 | Resonance |
| Travere Therapeutics, INC. | $16.84 | 2021 | |
| Neotract INC. | $15.21 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.34 | 2022 | |
| Amgen INC. | $13.86 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.